Medicina

Medicina y ciencias biológicas

1. Mesenchymal Stem Cells 100%
2. Chile 73%
3. Exosomes 30%
4. Bipolar Disorder 30%
5. Extracellular Vesicles 28%
6. Stem Cells 27%
7. Post-Synaptic Density 25%
8. Cell- and Tissue-Based Therapy 24%
9. Serogroup 23%
10. Pregnancy 21%
11. Pre-Eclampsia 18%
12. Mortality 18%
13. Vaccination 18%
14. Vaccines 17%
15. Fluoxetine 15%
16. Regulatory T-Lymphocytes 15%
17. Meningococcal Infections 15%
18. Therapeutics 15%
19. T-Lymphocytes 15%
20. Child 15%
21. Th17 Cells 15%
22. Pneumococcal Vaccines 14%
23. Pneumococcal Infections 14%
24. Kidney 14%
25. Coronavirus 13%
26. Gingival Crevicular Fluid 13%
27. Biomarkers 13%
28. Proteins 13%
29. Health 13%
30. Immunosuppressive Agents 12%
31. Rheumatoid Arthritis 12%
32. 10-valent pneumococcal conjugate vaccine 12%
33. Astrocytes 12%
34. Conjugate Vaccines 12%
35. Phenotype 11%
36. Peritoneal Dialysis 11%
37. Fetal Growth Retardation 11%
38. Renal Dialysis 11%
39. MicroRNAs 11%
40. Latin America 10%
41. Regeneration 10%
42. Systemic Lupus Erythematosus 10%
43. acylaminoacyl-peptidase 10%
44. Communicable Diseases 10%
45. Pneumonia 10%
46. Mothers 10%
47. Gestational Diabetes 10%
48. Immunization 9%
49. Mitochondria 9%
50. Neuronal Plasticity 9%
51. Seizures 9%
52. Spironolactone 9%
53. Peroxisome Proliferator-Activated Receptors 9%
54. Prosencephalon 9%
55. Neisseria meningitidis 9%
56. Autoimmune Experimental Encephalomyelitis 9%
57. Population 9%
58. Umbilical Cord 8%
59. Immunization Programs 8%
60. Neurogenesis 8%
61. Neurons 8%
62. N-Methyl-D-Aspartate Receptors 8%
63. Synapses 8%
64. Kainic Acid 8%
65. Neuropilin-1 8%
66. Incidence 8%
67. Chronic Renal Insufficiency 8%
68. Periodontitis 8%
69. Blood Vessels 7%
70. Macrophages 7%
71. Antidepressive Agents 7%
72. Interleukin-33 7%
73. Cohort Studies 7%
74. Safety 7%
75. NFATC Transcription Factors 7%
76. Depression 7%
77. Adult Respiratory Distress Syndrome 7%
78. Rheumatic Heart Disease 7%
79. Fructose-Bisphosphate Aldolase 7%
80. Brain-Derived Neurotrophic Factor 7%
81. Inflammation 6%
82. Fetus 6%
83. Dendritic Spines 6%
84. Pediatrics 6%
85. Th1 Cells 6%
86. Hypoxia 6%
87. Long-Term Potentiation 6%
88. Ischemia 6%
89. Obesity 6%
90. Autoimmune Diseases 6%
91. Chronic Kidney Failure 6%
92. In Vitro Techniques 6%
93. Neural Stem Cells 6%
94. Cold Temperature 6%
95. First Pregnancy Trimester 6%
96. Cost-Benefit Analysis 6%
97. Brain 6%
98. Genes 6%
99. Nitric Oxide 6%
100. Temperature 6%